Neuromeka Balance Sheet Health
Financial Health criteria checks 2/6
Neuromeka has a total shareholder equity of ₩18.5B and total debt of ₩39.2B, which brings its debt-to-equity ratio to 212%. Its total assets and total liabilities are ₩89.6B and ₩71.2B respectively.
Key information
212.0%
Debt to equity ratio
₩39.16b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩26.61b |
| Equity | ₩18.48b |
| Total liabilities | ₩71.16b |
| Total assets | ₩89.64b |
Financial Position Analysis
Short Term Liabilities: A348340's short term assets (₩44.3B) do not cover its short term liabilities (₩50.8B).
Long Term Liabilities: A348340's short term assets (₩44.3B) exceed its long term liabilities (₩20.4B).
Debt to Equity History and Analysis
Debt Level: A348340's net debt to equity ratio (68%) is considered high.
Reducing Debt: A348340's debt to equity ratio has reduced from 2738.1% to 212% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A348340 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A348340 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 40.9% each year